Literature DB >> 31929496

The Prognostic Role of a Combined Fibrinogen and Neutrophil-to-Lymphocyte Ratio Score in Patients with Resectable Hepatocellular Carcinoma: A Retrospective Study.

Weihao Kong1,2, Honghai Xu3,4, Jiongjiong Cheng1,2, Zheng Fang1,2, Hengyi Wang1,2, Jian Zhang5, Xingyu Wang1,2, Tianxing Dai5, Yufeng Gao3,6.   

Abstract

BACKGROUND Inflammation and activation of the coagulation cascades have a role in the pathogenesis of malignancy, including hepatocellular carcinoma (HCC). This retrospective study aimed to investigate the prognostic role of the combined fibrinogen and neutrophil-to-lymphocyte ratio (F-NLR) in patients with resectable HCC. MATERIAL AND METHODS This retrospective study included 292 patients with HCC who underwent surgical resection. The receiver operating characteristic (ROC) curve was used to determine the cut-off value of preoperative fibrinogen (Fib) levels and the neutrophil-to-lymphocyte ratio (NLR). The. Hyperfibrinogenemia was >3.35 g/L, and an increased NLR was ≥2.47. The F-NLR was calculated for all patients. Kaplan-Meier survival curves, univariate analysis, multivariate analysis, and subgroup analysis were used to identify independent prognostic factors for overall survival (OS) and disease-free survival (DFS). The receiver operating characteristic (ROC) curve analysis of the F-NLR score and OS, according to the Barcelona Clinic Liver Cancer (BCLC) stage, was performed. RESULTS Increased F-NLR scores were significantly associated with the presence of tumor thrombus (P=0.001), larger tumor diameter (P<0.001), vascular invasion (P<0.001), and increased BCLC stage (P<0.001). Multivariate analysis showed that the F-NLR score was an independent predictor of OS (P<0.001) and DFS (P=0.002). The prognostic role of F-NLR was significant for BCLC stage 0-I (P=0.004; P<0.001) and BCLC stage II-III (P=0.026; P=0.005) for OS and DFS, respectively. CONCLUSIONS In patients with resectable HCC, the combined F-NLR score, a new indicator of systemic inflammation, was an independent prognostic indicator.

Entities:  

Year:  2020        PMID: 31929496     DOI: 10.12659/MSM.918824

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  8 in total

Review 1.  Neutrophils as potential therapeutic targets in hepatocellular carcinoma.

Authors:  Daniel Geh; Jack Leslie; Rob Rumney; Helen L Reeves; Thomas G Bird; Derek A Mann
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-01-12       Impact factor: 46.802

2.  Radiofrequency Ablation (RFA) Combined with Transcatheter Arterial Chemoembolization (TACE) for Patients with Medium-to-Large Hepatocellular Carcinoma: A Retrospective Analysis of Long-Term Outcome.

Authors:  Weiwen Liu; Huihong Xu; Xihui Ying; Dengke Zhang; Linqiang Lai; Linyou Wang; Jianfei Tu; Jiansong Ji
Journal:  Med Sci Monit       Date:  2020-07-15

3.  C8B in Complement and Coagulation Cascades Signaling Pathway is a predictor for Survival in HBV-Related Hepatocellular Carcinoma Patients.

Authors:  Yuan Zhang; Xiaorong Chen; Yajuan Cao; Zongguo Yang
Journal:  Cancer Manag Res       Date:  2021-04-22       Impact factor: 3.989

4.  An m6A-Related lncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma.

Authors:  Zhenyu Zhang; Fangkai Wang; Jianlin Zhang; Wenjing Zhan; Gaosong Zhang; Chong Li; Tongyuan Zhang; Qianqian Yuan; Jia Chen; Manyu Guo; Honghai Xu; Feng Yu; Hengyi Wang; Xingyu Wang; Weihao Kong
Journal:  Front Pharmacol       Date:  2022-03-30       Impact factor: 5.810

5.  Combination of Preoperative Circulating Tumor Cell Count and Neutrophil-Lymphocyte Ratio for Prognostic Prediction in Hepatocellular Carcinoma Patients after Curative Hepatectomy.

Authors:  Hang-Hang Ni; Xi-Hua Yang; Cheng-Lei Yang; Qian Zhang; Jing-Xuan Xu; Lu-Nan Qi; Bang-De Xiang
Journal:  Biomed Res Int       Date:  2022-07-16       Impact factor: 3.246

6.  Neutrophil to lymphocyte ratio and albumin bilirubin grade in hepatocellular carcinoma: A systematic review.

Authors:  Ayman Bannaga; Ramesh P Arasaradnam
Journal:  World J Gastroenterol       Date:  2020-09-07       Impact factor: 5.742

7.  Prognostic value of combined pretreatment fibrinogen and neutrophil-lymphocyte ratio in digestive system cancers: a meta-analysis of 17 retrospective studies.

Authors:  Rongqiang Liu; Tianxing Dai; Shiyang Zheng; Mingbin Deng; Guozhen Lin; Yuanda Bao; Zhihua Guo; Guoying Wang
Journal:  Transl Cancer Res       Date:  2021-01       Impact factor: 1.241

8.  Preoperative lymphocyte-monocyte ratio is not an independent prognostic factor in M0 (stage I-III) esophageal squamous cell carcinomas.

Authors:  Chao Chen; Gang Chen; Yanran Wu; Jing Li
Journal:  Transl Cancer Res       Date:  2020-05       Impact factor: 1.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.